Conflicting industry views over need for devices head at UK's MHRA (Medicines and healthcare Products Regulatory Agency)
This article was originally published in Clinica
Following Dr Ian Gibson's raising the issue of why there was no longer a head of the devices and diagnostics section at the Medicines and healthcare Products Regulatory Agency, Amanda Maxwell spoke to the Association of British Healthcare Industries (ABHI), the British In Vitro Diagnostics Association and the British Healthcare Trades Association to see how they are coping with the lack of authority figure for devices and found two surprisingly different views
You may also be interested in...
Europe's largest online pharmacy is calling for online sales of OTC medicines to be allowed in its home market Switzerland, to increase the supply of crucial products to help people manage the symptoms of COVID-19, such as headaches, fever, diarrhoea, coughs, colds or nausea.
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.
Novartis's Jakavi joins the likes of Roche's Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients.